(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
Emerging Growth Company |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL) |
Applied Materials, Inc. (Registrant) | ||||||||||||||
Date: | August 13, 2020 | By: | /s/ Teri A. Little | |||||||||||
Teri A. Little | ||||||||||||||
Senior Vice President, Chief Legal Officer and Corporate Secretary |
Q3 FY2020 | Q3 FY2019 | Change | |||||||||||||||
(In millions, except per share amounts and percentages) | |||||||||||||||||
Net sales | $ | 4,395 | $ | 3,562 | 23% | ||||||||||||
Gross margin | 44.5 | % | 43.7 | % | 0.8 points | ||||||||||||
Operating margin | 25.2 | % | 22.5 | % | 2.7 points | ||||||||||||
Net income | $ | 841 | $ | 571 | 47% | ||||||||||||
Diluted earnings per share | $ | 0.91 | $ | 0.61 | 49% | ||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||
Non-GAAP adjusted gross margin | 45.0 | % | 44.0 | % | 1.0 points | ||||||||||||
Non-GAAP adjusted operating margin | 26.4 | % | 23.0 | % | 3.4 points | ||||||||||||
Non-GAAP adjusted net income | $ | 976 | $ | 692 | 41% | ||||||||||||
Non-GAAP adjusted diluted EPS | $ | 1.06 | $ | 0.74 | 43% |
Semiconductor Systems | Q3 FY2020 | Q3 FY2019 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 2,916 | $ | 2,273 | |||||||
Foundry, logic and other | 55 | % | 49 | % | |||||||
DRAM | 22 | % | 27 | % | |||||||
Flash memory | 23 | % | 24 | % | |||||||
Operating income | 958 | 613 | |||||||||
Operating margin | 32.9 | % | 27.0 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 982 | $ | 624 | |||||||
Non-GAAP adjusted operating margin | 33.7 | % | 27.5 | % |
Applied Global Services | Q3 FY2020 | Q3 FY2019 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 1,034 | $ | 931 | |||||||
Operating income | 273 | 259 | |||||||||
Operating margin | 26.4 | % | 27.8 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 277 | $ | 259 | |||||||
Non-GAAP adjusted operating margin | 26.8 | % | 27.8 | % |
Display and Adjacent Markets | Q3 FY2020 | Q3 FY2019 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 425 | $ | 339 | |||||||
Operating income | 83 | 41 | |||||||||
Operating margin | 19.5 | % | 12.1 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 87 | $ | 44 | |||||||
Non-GAAP adjusted operating margin | 20.5 | % | 13.0 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | July 26, 2020 | July 28, 2019 | July 26, 2020 | July 28, 2019 | |||||||||||||||||||
Net sales | $ | 4,395 | $ | 3,562 | $ | 12,514 | $ | 10,854 | |||||||||||||||
Cost of products sold | 2,440 | 2,005 | 6,952 | 6,102 | |||||||||||||||||||
Gross profit | 1,955 | 1,557 | 5,562 | 4,752 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research, development and engineering | 572 | 515 | 1,674 | 1,539 | |||||||||||||||||||
Marketing and selling | 130 | 128 | 395 | 392 | |||||||||||||||||||
General and administrative | 145 | 112 | 411 | 335 | |||||||||||||||||||
Total operating expenses | 847 | 755 | 2,480 | 2,266 | |||||||||||||||||||
Income from operations | 1,108 | 802 | 3,082 | 2,486 | |||||||||||||||||||
Interest expense | 61 | 58 | 181 | 178 | |||||||||||||||||||
Interest and other income (loss), net | (7) | 38 | 22 | 121 | |||||||||||||||||||
Income before income taxes | 1,040 | 782 | 2,923 | 2,429 | |||||||||||||||||||
Provision for income taxes | 199 | 211 | 435 | 421 | |||||||||||||||||||
Net income | $ | 841 | $ | 571 | $ | 2,488 | $ | 2,008 | |||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ | 0.92 | $ | 0.61 | $ | 2.71 | $ | 2.13 | |||||||||||||||
Diluted | $ | 0.91 | $ | 0.61 | $ | 2.69 | $ | 2.11 | |||||||||||||||
Weighted average number of shares: | |||||||||||||||||||||||
Basic | 915 | 929 | 916 | 943 | |||||||||||||||||||
Diluted | 922 | 937 | 924 | 950 |
(In millions) | July 26, 2020 | October 27, 2019 | |||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 4,350 | $ | 3,129 | |||||||
Short-term investments | 406 | 489 | |||||||||
Accounts receivable, net | 2,806 | 2,533 | |||||||||
Inventories | 3,952 | 3,474 | |||||||||
Other current assets | 734 | 581 | |||||||||
Total current assets | 12,248 | 10,206 | |||||||||
Long-term investments | 1,538 | 1,703 | |||||||||
Property, plant and equipment, net | 1,530 | 1,529 | |||||||||
Goodwill | 3,474 | 3,399 | |||||||||
Purchased technology and other intangible assets, net | 157 | 156 | |||||||||
Deferred income taxes and other assets | 2,224 | 2,031 | |||||||||
Total assets | $ | 21,171 | $ | 19,024 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Current portion of long-term debt | $ | — | $ | 600 | |||||||
Accounts payable and accrued expenses | 2,895 | 2,511 | |||||||||
Contract liabilities | 1,390 | 1,336 | |||||||||
Total current liabilities | 4,285 | 4,447 | |||||||||
Long-term debt, net of current portion | 5,447 | 4,713 | |||||||||
Income taxes payable | 1,237 | 1,275 | |||||||||
Other liabilities | 633 | 375 | |||||||||
Total liabilities | 11,602 | 10,810 | |||||||||
Total stockholders’ equity | 9,569 | 8,214 | |||||||||
Total liabilities and stockholders’ equity | $ | 21,171 | $ | 19,024 |
(In millions) | Three Months Ended | Nine Months Ended | |||||||||||||||||||||
July 26, 2020 | July 28, 2019 | July 26, 2020 | July 28, 2019 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net income | $ | 841 | $ | 571 | $ | 2,488 | $ | 2,008 | |||||||||||||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 94 | 89 | 279 | 271 | |||||||||||||||||||
Share-based compensation | 70 | 67 | 234 | 197 | |||||||||||||||||||
Deferred income taxes | 79 | 8 | 98 | 57 | |||||||||||||||||||
Other | 33 | (10) | 55 | (19) | |||||||||||||||||||
Net change in operating assets and liabilities | (250) | 62 | (665) | (93) | |||||||||||||||||||
Cash provided by operating activities | 867 | 787 | 2,489 | 2,421 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Capital expenditures | (87) | (93) | (260) | (344) | |||||||||||||||||||
Cash paid for acquisitions, net of cash acquired | (80) | (5) | (107) | (28) | |||||||||||||||||||
Proceeds from sales and maturities of investments | 353 | 479 | 1,388 | 1,385 | |||||||||||||||||||
Purchases of investments | (178) | (543) | (1,010) | (1,370) | |||||||||||||||||||
Cash provided by (used in) investing activities | 8 | (162) | 11 | (357) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Debt borrowings, net of issuance costs | 1,481 | — | 2,979 | — | |||||||||||||||||||
Debt repayments | (2,882) | — | (2,882) | — | |||||||||||||||||||
Proceeds from common stock issuances | — | — | 91 | 73 | |||||||||||||||||||
Common stock repurchases | (200) | (528) | (599) | (1,903) | |||||||||||||||||||
Tax withholding payments for vested equity awards | (3) | (3) | (166) | (83) | |||||||||||||||||||
Payments of dividends to stockholders | (202) | (196) | (587) | (577) | |||||||||||||||||||
Cash used in financing activities | (1,806) | (727) | (1,164) | (2,490) | |||||||||||||||||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | (931) | (102) | 1,336 | (426) | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents—beginning of period | 5,396 | 3,116 | 3,129 | 3,440 | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents — end of period | $ | 4,465 | $ | 3,014 | $ | 4,465 | $ | 3,014 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ | 4,350 | $ | 3,014 | $ | 4,350 | $ | 3,014 | |||||||||||||||
Restricted cash equivalents included in deferred income taxes and other assets | 115 | — | 115 | — | |||||||||||||||||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 4,465 | $ | 3,014 | $ | 4,465 | $ | 3,014 | |||||||||||||||
Supplemental cash flow information: | |||||||||||||||||||||||
Cash payments for income taxes | $ | 238 | $ | 221 | $ | 519 | $ | 453 | |||||||||||||||
Cash refunds from income taxes | $ | — | $ | 2 | $ | 5 | $ | 20 | |||||||||||||||
Cash payments for interest | $ | 41 | $ | 33 | $ | 151 | $ | 143 |
(In millions) | Q3 FY2020 | Q3 FY2019 | |||||||||
Unallocated net sales | $ | 20 | $ | 19 | |||||||
Unallocated cost of products sold and expenses | (156) | (63) | |||||||||
Share-based compensation | (70) | (67) | |||||||||
Total | $ | (206) | $ | (111) |
Q3 FY2020 | Q3 FY2019 | ||||||||||
Net Sales by Geography (In millions) | |||||||||||
United States | 399 | 552 | |||||||||
% of Total | 9 | % | 15 | % | |||||||
Europe | 196 | 162 | |||||||||
% of Total | 5 | % | 5 | % | |||||||
Japan | 472 | 556 | |||||||||
% of Total | 11 | % | 16 | % | |||||||
Korea | 1,051 | 445 | |||||||||
% of Total | 24 | % | 12 | % | |||||||
Taiwan | 687 | 596 | |||||||||
% of Total | 16 | % | 17 | % | |||||||
Southeast Asia | 120 | 134 | |||||||||
% of Total | 2 | % | 4 | % | |||||||
China | 1,470 | 1,117 | |||||||||
% of Total | 33 | % | 31 | % | |||||||
Employees (In thousands) | |||||||||||
Regular Full Time | 23.6 | 21.6 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | July 26, 2020 | July 28, 2019 | July 26, 2020 | July 28, 2019 | |||||||||||||||||||
Non-GAAP Adjusted Gross Profit | |||||||||||||||||||||||
Reported gross profit - GAAP basis | $ | 1,955 | $ | 1,557 | $ | 5,562 | $ | 4,752 | |||||||||||||||
Certain items associated with acquisitions1 | 8 | 9 | 25 | 28 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | 15 | — | 23 | — | |||||||||||||||||||
Non-GAAP adjusted gross profit | $ | 1,978 | $ | 1,566 | $ | 5,610 | $ | 4,780 | |||||||||||||||
Non-GAAP adjusted gross margin | 45.0 | % | 44.0 | % | 44.8 | % | 44.0 | % | |||||||||||||||
Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,108 | $ | 802 | $ | 3,082 | $ | 2,486 | |||||||||||||||
Certain items associated with acquisitions1 | 12 | 13 | 38 | 41 | |||||||||||||||||||
Acquisition integration and deal costs | 20 | 5 | 54 | 12 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | 20 | — | 30 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,160 | $ | 820 | $ | 3,204 | $ | 2,539 | |||||||||||||||
Non-GAAP adjusted operating margin | 26.4 | % | 23.0 | % | 25.6 | % | 23.4 | % | |||||||||||||||
Non-GAAP Adjusted Net Income | |||||||||||||||||||||||
Reported net income - GAAP basis | $ | 841 | $ | 571 | $ | 2,488 | $ | 2,008 | |||||||||||||||
Certain items associated with acquisitions1 | 12 | 13 | 38 | 41 | |||||||||||||||||||
Acquisition integration and deal costs | 20 | 5 | 54 | 12 | |||||||||||||||||||
Certain incremental expenses related to COVID-195 | 20 | — | 30 | — | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | (8) | 1 | (1) | (6) | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | (5) | (9) | (1) | (25) | |||||||||||||||||||
Loss on early extinguishment of debt | 33 | — | 33 | — | |||||||||||||||||||
Income tax effect of share-based compensation2 | 12 | — | (13) | (4) | |||||||||||||||||||
Income tax effect of changes in applicable U.S. tax laws3 | — | — | — | (24) | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 67 | 115 | 104 | 56 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | (1) | (1) | (5) | 75 | |||||||||||||||||||
Income tax effect of non-GAAP adjustments4 | (15) | (3) | (30) | (2) | |||||||||||||||||||
Non-GAAP adjusted net income | $ | 976 | $ | 692 | $ | 2,697 | $ | 2,131 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. | ||||
3 | Charges to income tax provision related to a one-time transition tax as a result of U.S. tax legislation. | ||||
4 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. | ||||
5 | Temporary incremental employee compensation during the COVID-19 pandemic. |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | July 26, 2020 | July 28, 2019 | July 26, 2020 | July 28, 2019 | |||||||||||||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | |||||||||||||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 0.91 | $ | 0.61 | $ | 2.69 | $ | 2.11 | |||||||||||||||
Certain items associated with acquisitions | 0.01 | 0.01 | 0.04 | 0.04 | |||||||||||||||||||
Acquisition integration and deal costs | 0.02 | 0.01 | 0.05 | 0.01 | |||||||||||||||||||
Certain incremental expenses related to COVID-19 | 0.02 | — | 0.03 | — | |||||||||||||||||||
Loss on early extinguishment of debt | 0.03 | — | 0.03 | — | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | (0.01) | — | — | — | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | — | (0.01) | — | (0.03) | |||||||||||||||||||
Income tax effect of share-based compensation | 0.01 | — | (0.02) | — | |||||||||||||||||||
Income tax effect of changes in applicable U.S. tax laws | — | — | — | (0.03) | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 0.07 | 0.12 | 0.11 | 0.06 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | — | — | (0.01) | 0.08 | |||||||||||||||||||
Non-GAAP adjusted earnings per diluted share | $ | 1.06 | $ | 0.74 | $ | 2.92 | $ | 2.24 | |||||||||||||||
Weighted average number of diluted shares | 922 | 937 | 924 | 950 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | July 26, 2020 | July 28, 2019 | July 26, 2020 | July 28, 2019 | |||||||||||||||||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 958 | $ | 613 | $ | 2,655 | $ | 1,823 | |||||||||||||||
Certain items associated with acquisitions1 | 9 | 11 | 29 | 32 | |||||||||||||||||||
Acquisition integration costs | 1 | — | 1 | — | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | 14 | — | 20 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 982 | $ | 624 | $ | 2,705 | $ | 1,855 | |||||||||||||||
Non-GAAP adjusted operating margin | 33.7 | % | 27.5 | % | 32.6 | % | 27.6 | % | |||||||||||||||
AGS Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 273 | $ | 259 | $ | 807 | $ | 827 | |||||||||||||||
Certain incremental expenses related to COVID-192 | 4 | — | 8 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 277 | $ | 259 | $ | 815 | $ | 827 | |||||||||||||||
Non-GAAP adjusted operating margin | 26.8 | % | 27.8 | % | 26.7 | % | 28.7 | % | |||||||||||||||
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 83 | $ | 41 | $ | 196 | $ | 198 | |||||||||||||||
Certain items associated with acquisitions1 | 3 | 2 | 9 | 9 | |||||||||||||||||||
Acquisition integration costs | — | 1 | — | 1 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | 1 | — | 1 | — | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 87 | $ | 44 | $ | 206 | $ | 208 | |||||||||||||||
Non-GAAP adjusted operating margin | 20.5 | % | 13.0 | % | 18.4 | % | 17.4 | % | |||||||||||||||
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
Three Months Ended | |||||
(In millions, except percentages) | July 26, 2020 | ||||
Provision for income taxes - GAAP basis (a) | $ | 199 | |||
Income tax effect of share-based compensation | (12) | ||||
Income tax effects related to intra-entity intangible asset transfers | (67) | ||||
Resolutions of prior years’ income tax filings and other tax items | 1 | ||||
Income tax effect of non-GAAP adjustments | 15 | ||||
Non-GAAP adjusted provision for income taxes (b) | $ | 136 | |||
Income before income taxes - GAAP basis (c) | $ | 1,040 | |||
Certain items associated with acquisitions | 12 | ||||
Acquisition integration and deal costs | 20 | ||||
Certain incremental expenses related to COVID-19 | 20 | ||||
Realized loss (gain) on strategic investments, net | (8) | ||||
Unrealized loss (gain) on strategic investments, net | (5) | ||||
Loss on early extinguishment of debt | 33 | ||||
Non-GAAP adjusted income before income taxes (d) | $ | 1,112 | |||
Effective income tax rate - GAAP basis (a/c) | 19.1 | % | |||
Non-GAAP adjusted effective income tax rate (b/d) | 12.2 | % |